Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialized player in the healthcare sector, is capturing investor attention with its focus on rare disease treatments and a noteworthy potential upside of 77.73%...
Castle Biosciences, Inc. (NASDAQ: CSTL) stands at the forefront of the molecular diagnostics sector, specializing in innovative test solutions for dermatologic cancers, Barrett’s esophagus, and mental health conditions. Headquartered in..
Ardelyx, Inc. (NASDAQ: ARDX), a prominent player in the biotechnology sector, has captured investor attention with a promising potential upside of nearly 97%. Based in Waltham, Massachusetts, Ardelyx is at..
Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a notable player in the healthcare sector specializing in pain management pharmaceuticals, has been capturing investor attention with its impressive growth metrics and strategic market..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a burgeoning player in the biotechnology sector, is capturing investor attention with its robust pipeline targeting hereditary angioedema (HAE), a disease area with significant unmet..
For investors with an eye for biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) offers a compelling opportunity. With a focus on innovative therapies targeting G protein-coupled receptors (GPCRs), Tectonic is making..
Kura Oncology, Inc. (NASDAQ: KURA), a promising player in the biotechnology sector, has been capturing the attention of investors with its compelling potential upside and strategic collaborations. Headquartered in San..
Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is capturing investor attention with its pioneering gene and cell therapies. With a robust market capitalization of $1.28 billion,..
Upstream Bio, Inc. (NASDAQ: UPB), a clinical-stage biotechnology firm focused on developing innovative treatments for inflammatory diseases, particularly severe respiratory disorders, is drawing significant attention from investors with its remarkable..
Stoke Therapeutics, Inc. (NASDAQ: STOK), a biotechnology company specializing in the development of treatments for severe genetic disorders, has been gaining attention in the healthcare sector. With the stock trading..
REGENXBIO Inc. (NASDAQ: RGNX) captures the attention of investors with its innovative gene therapy solutions and a significant potential upside. With a market capitalization of $650.51 million, this clinical-stage biotechnology..
For investors with an eye on the biotechnology sector, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) presents a compelling opportunity. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts, is pioneering therapies for..
Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with its innovative approach to developing therapeutics for diseases underserved by current treatments. Based in the United Kingdom, this..
Intellia Therapeutics, Inc. (NTLA), a trailblazer in the field of gene editing, is capturing investor attention with a remarkable potential upside of 134.89%. This biotechnology company is at the forefront..
SIGA Technologies Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company headquartered in New York, focuses primarily on the health security market in the United States. Known for its lead product, TPOXX,..
AxoGen, Inc. (AXGN), a key player in the medical devices sector, continues to capture investor attention with its innovative approach to peripheral nerve regeneration and repair. Headquartered in Alachua, Florida,..
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is making waves in the biotechnology sector with its focus on developing groundbreaking gene therapies for rare and life-threatening diseases. With a market capitalization of..
RxSight, Inc. (NASDAQ: RXST), a promising player in the healthcare sector, specifically in the medical devices industry, has been making waves with its cutting-edge technology in cataract surgery. Headquartered in..
Maze Therapeutics, Inc. (NASDAQ: MAZE), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline of precision medicines. Based in South San Francisco, California, Maze..
Cel-Sci Corporation (NASDAQ: CVM) is a clinical-stage biotechnology firm that has captured the attention of investors with its ambitious approach to leveraging the immune system in the fight against cancer..
